The invention relates to a medical technology implant and a method for coating an implant.
EP 3 035 891 B1 discloses an anatomically adapted orthopedic implant. This is a tibial implant for implantation on a proximal tibia of a patient's knee joint. The implant has a cobalt-chromium alloy as the base material. Biocompatible plastics such as high molecular weight polyethylene (HMWPE), ultra-high molecular weight polyethylene (UHMWPE) or polyether ether ketone (PEEK) are suggested for a joint element.
DE 20 2005 005 405 U1 discloses an implant for insertion into a human or animal body, which has a bone contact surface which is at least partially covered with an osteointegrative layer, an intermediate layer being provided between the osteointegrative layer and the bone contact surface of the base body. The base body according to DE 20 2005 005 405 U1 can be made, for example, from a ceramic or a polymer, in particular PEEK or UHMWPE. The osteointegrative layer can be a porous pure titanium layer. As far as the intermediate layer is concerned, it is suggested to apply it by cold gas spraying.
EP 1 790 224 B1 discloses an antimicrobial layer material which is constructed in multiple layers, that is to say from a biocide layer and a transport control layer covering said biocide layer. The antimicrobial layer material is suitable, among other things, for coating a catheter, a contact lens, an implant, a medical nail or a dental implant.
Regarding the material UHMWPE, reference is also made to the following dissertation: “Beurteilung von vernetztem UHMWPE hinsichtlich seiner Eignung als Implantatwerkstoff für Hüftgelenkschalen [in EN: Assessment of networked UHMWPE with regard to its suitability as an implant material for hip joint shells]”, Dipl.-Ing. Ingo John, TU Berlin, Oct. 23, 2003
The dissertation focuses in particular on the possibilities of FTIR analysis (Fourier transform infrared spectroscopy). The dissertation also elaborates on studies that concern the oxidation index of gamma-irradiated UHMWPE.
The invention is based on the object of refining medical technology implants which include UHMWPE compared to the stated prior art, particularly in terms of durability.
The configurations and advantages of the invention explained below in connection with the coating method also apply correspondingly to the device, that is to say to the medical technology implant, and vice versa.
The implant has ultra-high molecular weight polyethylene as the base material and a coating thereon, which comprises a biocide layer and a barrier layer covering said biocide layer and not necessarily being absolutely impermeable. In comparison to the uncoated base material, the coating is designed to at least inhibit the access of substances that promote corrosion, that is to say promote degradation, to the base material, in particular oxygen, and to prevent or at least reduce the release of substances from the base material. The material release mentioned could, for example, be the release of components of the base material itself or the release of degradation products.
An antimicrobial layer material according to the already mentioned patent specification EP 1 790 224 B1 is particularly suitable as a coating for the implant. As part of the coating process, a multi-layer layer consisting of a biocide layer and a barrier layer is generally applied to ultra-high molecular weight polyethylene, which fulfills a mechanical function.
The ultra-high molecular weight polyethylene (UHMWPE) can be cross-linked by beta or gamma radiation, whereby the cross-linking can occur either before or after the application of the multi-layer antimicrobial layer. Applying the coating before beta or gamma irradiation has the advantage that the base material is already protected from oxygen during the irradiation. This means that the adverse effects of radicals that could arise from irradiation and attack the workpiece surface are completely or largely prevented. In particular, the need to carry out radiation crosslinking to protect the base material in a nitrogen atmosphere can be eliminated.
The radiation-crosslinked UHMWPE serving as the base material of the implant can, for example, have a molecular weight in the range of 3 million to 7 million g/mol, a molecular weight in the range of 7 million to 10 million g/mol, or even a molecular weight of more than 10 million g/mol.
In a simplified configuration, a separate biocide-containing layer is eliminated. In this case, the base material, i.e. UHMWPE, is covered in particular by a pure polysiloxane layer. The polysiloxane layer reduces the entry of oxygen or, provided it is sufficiently thick, excludes it completely, which in any case significantly increases the service life of the product. Instead of a polysiloxane layer, another oxygen-impermeable layer, optionally supplemented by a biocide layer, can also be applied to the UHMWPE.
The coating of the implant protects the base material in particular from oxidation. At the same time, biocidal active ingredients can be released through the barrier layer. The biocidal active ingredient is, for example, selected from the group consisting of silver, copper and zinc, ions thereof and metal complexes thereof, or a mixture or alloy comprising two or more of these elements.
A particular advantage of the biocide layer is that it prevents the formation of a biofilm on the surface of the implant. Overall, the coating of the implant represents a highly effective barrier both to the inside and to the outside. Among other things, the coating prevents the ultra-high molecular weight polyethylene from becoming brittle. Ultimately, the coating dramatically increases the service life of the implant.
Thickness and porosity of the barrier layer are preferably adjusted such that the biocidal active ingredient is released from the biocide layer through the barrier layer in an antimicrobial, but not cytotoxic, amount. The biocidal active ingredient has, for example, an average grain size of 5 to 100 nm, with the average thickness of the biocide layer being 5 to 100 nm and the average thickness of the barrier layer being 5 to 500 nm.
The base material of the barrier layer can, for example, be selected from the group comprising an organic base material, in particular a plasma polymer, a sol-gel, a lacquer and a siliconized base material. Alternatively, an inorganic base material of the barrier layer can be selected, for example, from the group comprising SiO2, SiC, a metal oxide, in particular TiO2 Al2O3, and a non-biocidal metal, in particular titanium and medical stainless steel.
The multi-layer coating only partially covers the base material. Here, the multi-layer coating covers the base material, i.e. the UHMWPE, in a surface section lying outside a sliding surface of the implant, whereas the sliding surface of the same implant is formed by uncoated UHMWPE or by UHMWPE coated in another way. In addition to articulation surfaces, conical connections of the implant can also remain uncoated.
The implant can in particular be a joint implant, for example a hip or knee joint endoprosthesis or a component for elbows, ankle joints or shoulder joints. Furthermore, the multi-layer coating, which is made up of a biocide layer and a barrier layer, can be used, for example, for surgical sutures or for ligament replacements, in particular cruciate ligaments.
In any case, advantages in terms of the oxidation index and/or wear can be achieved by coating the implant. The adjustable hydrophilicity of the biocide layer is also important. In particular, the coating can lead to better wetting with water or synovial fluid compared to hydrophobic UHMWPE, which improves the wear characteristics.
It is assumed that radiation crosslinking generally improves the wear resistance of polyethylene, but at the same time carries disadvantages in terms of oxidation, i.e. aging, of the material. This target conflict is eliminated or at least reduced by the coating on the radiation-crosslinked material. The improvements achieved in terms of oxidation compared to uncoated UHMWPE are noticeable to a depth of more than 1 mm below the surface of the base material.
The coating is applied in typical processing at a temperature of approx. 40° C., which reliably avoids any thermal damage to the base material. The layer thickness is, for example, 90 nm. Depending on the process parameters, the coating can be made transparent or colored. In any case, the shelf life of the implant can be increased by the oxidation protection achieved on the surface of the implant, in particular the surface of the prosthesis. In addition, advantages can be achieved in production and logistics by not requiring packaging under inert gas, in contrast to conventional products intended for corresponding purposes.
To the extent that oxidation still occurs in the coated implant, whose coating, among other things, provides a shield against air oxygen, it is drastically delayed compared to conventional, uncoated UHMWPE implants, which significantly increases the service life of the implant.
An exemplary embodiment of the invention are explained in more detail below with reference to a drawing. In the figures:
An implant, marked all together with reference numeral 1, is designed as an inlay of an artificial joint. Implant 1 has a modified hemispherical basic shape, with a spherical surface section 2 being adjoined by a frustoconical surface section 3. In the middle of spherical surface section 2, in the arrangement according to
The coating 10, which is partially located on the outside of implant 1, is made up of a biocide layer and a barrier layer covering said biocide layer and is applied directly to the base material of implant 1. The base material of implant 1 is ultra-high molecular weight polyethylene, which was cross-linked using beta or gamma radiation.
Implant 1 is intended to be inserted into an outer part 6, which is visible in
In the diagram according to
In addition, a comparison curve VK is plotted in the diagram according to
Number | Date | Country | Kind |
---|---|---|---|
102021125788.3 | Oct 2021 | DE | national |
This application is a National Stage Application of PCT/EP2022/077153, filed Sep. 29, 2022, which claims benefit of priority to German Patent Application No. 102021125788.3, filed Oct. 5, 2021, and which applications are incorporated herein by reference. To the extent appropriate, a claim of priority is made to each of the above disclosed applications.
Filing Document | Filing Date | Country | Kind |
---|---|---|---|
PCT/EP2022/077153 | 9/29/2022 | WO |